Company
Open menu
Company Overview
Board of Directors
Executive Team
Advisory Board
Pipeline
Open menu
Product Overview
AR-301 (Tosatoxumab)
AR-320 (Suvratoxumab)
AR-501 (Panaecin™)
AR-701 (COVID-19 mAb)
Preclinical
AR-401
Out-licensed Products
AR-105 (Aerucin®)
AR-101 (Aerumab™)
AR-201
TECHNOLOGY
Open menu
Technology Overview
⅄PEX™
MabIgX®
Therapeutic Targets
HAP / VAP
VAP Prevention
Cystic Fibrosis
COVID-19 Disease
Investors
Contact Us
Open menu
Contact Us
Careers
X
Search for:
Search Button
Company
Open menu
Company Overview
Board of Directors
Executive Team
Advisory Board
Pipeline
Open menu
Product Overview
AR-301 (Tosatoxumab)
AR-320 (Suvratoxumab)
AR-501 (Panaecin™)
AR-701 (COVID-19 mAb)
Preclinical
AR-401
Out-licensed Products
AR-105 (Aerucin®)
AR-101 (Aerumab™)
AR-201
TECHNOLOGY
Open menu
Technology Overview
⅄PEX™
MabIgX®
Therapeutic Targets
HAP / VAP
VAP Prevention
Cystic Fibrosis
COVID-19 Disease
Investors
Contact Us
Open menu
Contact Us
Careers
X
Search for:
Search Button
Events and Webcasts
Corporate Governance
Open menu
Board of Directors
Board Committees
News Releases
SEC Filings
Stock Information
Open menu
Historical Stock Price
Analyst Coverage
Events and Webcasts
Publications and Posters
Investor Alerts
Investor Inquiries
X
Corporate Governance
Open menu
Board of Directors
Board Committees
News Releases
SEC Filings
Stock Information
Open menu
Historical Stock Price
Analyst Coverage
Events and Webcasts
Publications and Posters
Investor Alerts
Investor Inquiries
X
Past Events
Tuesday, September 15, 2020
9:20am EDT
2020 Cantor Fitzgerald Virtual Global Healthcare Conference More
Tuesday, June 30, 2020
11:00am EDT
Cantor Symposium: Winning Ways to Treat Infections and COVID-19
Thursday, June 25, 2020
11:00am EDT
Cantor Virtual Fireside Chat
Tuesday, May 5, 2020
10:30am - 12:00pm EDT
Maxim Group’s Infectious Disease Virtual Conference More
Monday, March 16, 2020
32nd Annual ROTH Conference More
Friday, January 24, 2020
19th Annual CHI PepTalk Conference More
San Diego, CA
1
2
3
4